These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9141879)

  • 1. Faulty prescription--an avoidable cause of multidrug resistance tuberculosis.
    Jain RF
    J Indian Med Assoc; 1996 Oct; 94(10):385-8. PubMed ID: 9141879
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of tuberculosis in the adult].
    Schrappe M; Wassermann K; Kroegel C
    Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936
    [No Abstract]   [Full Text] [Related]  

  • 3. [Infections with Mycobacterium tuberculosis and MOTT (Mycobacteria other than tuberculosis) in HIV infected and AIDS patients].
    Armbruster C
    Wien Med Wochenschr; 1994; 144(8-9):182-6. PubMed ID: 7941606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hanging in there for a new TB drug.
    Bateman C
    S Afr Med J; 2000 Apr; 90(4):336-7. PubMed ID: 10957914
    [No Abstract]   [Full Text] [Related]  

  • 5. A new epidemic.
    Mukherjee B
    J Indian Med Assoc; 1997 Apr; 95(4):119. PubMed ID: 9357279
    [No Abstract]   [Full Text] [Related]  

  • 6. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controversy over tuberculosis therapy in HIV infected patients. Isoniazide therapy--brief chemotherapy].
    Arnheim K
    Fortschr Med; 1995 Dec; 113(35-36):14-5. PubMed ID: 8582689
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical aspects and therapy of tuberculosis].
    Höffken G; Deppermann KM
    Internist (Berl); 1995 Oct; 36(10):961-9. PubMed ID: 7499072
    [No Abstract]   [Full Text] [Related]  

  • 9. [Renaissance of tuberculosis?].
    Meyer FJ; Konietzko N
    Internist (Berl); 1995 Dec; 36(12):1162-73. PubMed ID: 8567222
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wrong drug used for tuberculosis.
    Kelly PM
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):385. PubMed ID: 9432398
    [No Abstract]   [Full Text] [Related]  

  • 12. Timing of antiretroviral drugs during tuberculosis therapy.
    Kadhiravan T
    N Engl J Med; 2010 Jun; 362(22):2138; author reply 2138-9. PubMed ID: 20527060
    [No Abstract]   [Full Text] [Related]  

  • 13. [Guidelines for chemotherapy of tuberculosis. German Central Committee for the Control of Tuberculosis].
    Ferlinz R
    Pneumologie; 1995 Mar; 49(3):217-25. PubMed ID: 7753768
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidemiology of multi-drug resistant tuberculosis in AIDS].
    Moro ML
    Recenti Prog Med; 1999 Oct; 90(10):515-21. PubMed ID: 10592736
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis control in India--past, present and future.
    Prabhakar R
    J Indian Med Assoc; 2000 Mar; 98(3):123-5. PubMed ID: 11016168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2009 Oct; 7(86):75-82; quiz 2 p after 82. PubMed ID: 19794340
    [No Abstract]   [Full Text] [Related]  

  • 17. Current recommendations of chemotherapy and pharmacology of antituberculosis drugs.
    Bhattacharyya P
    J Indian Med Assoc; 2000 Mar; 98(3):119-22, 129. PubMed ID: 11016167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tuberculosis and nontuberculous mycobacterial infections].
    Wagner D; Kern WV
    Dtsch Med Wochenschr; 2011 Apr; 136(14):691-4. PubMed ID: 21448828
    [No Abstract]   [Full Text] [Related]  

  • 19. The Revised National Tuberculosis Control Programme in India: time for revision of treatment regimens and rapid upscaling of DOTS-plus initiative.
    Bhargava A; Jain Y
    Natl Med J India; 2008; 21(4):187-91. PubMed ID: 19267041
    [No Abstract]   [Full Text] [Related]  

  • 20. Southern Africa is moving swiftly to combat the threat of XDR-TB.
    Wise J
    Bull World Health Organ; 2006 Dec; 84(12):924-5. PubMed ID: 17242824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.